FDA approves Tecartus, cell-based gene therapy to treat relapsed or refractory MCL in adults
It also received ‘Orphan Drug’ designation, which provides incentives to assist and encourage the development of drugs for rare…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.